About Quris Ai
Quris Ai is a company based in Tel Aviv-yafo (Israel) founded in 2020 by Yossi Haran and Isaac Bentwich. Quris Ai has raised $37 million across 3 funding rounds from investors including iAngels, SoftBank Vision Fund and GlenRock Israel. Quris Ai has completed 1 acquisition, including Nortis. Quris Ai offers products and services including Bio-AI Clinical Prediction Platform. Quris Ai operates in a competitive market with competitors including Sable Bio, Mensura Health, Intero Biosystems, Metsystem and Pharmacovigilance, among others.
- Headquarter Tel Aviv-yafo, Israel
- Founders Yossi Haran, Isaac Bentwich
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quris Technologies Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quris Ai
Quris Ai offers a comprehensive portfolio of products and services, including Bio-AI Clinical Prediction Platform.
Predicts drug safety using machine-learning trained on bio-data.
People of Quris Ai
Unlock access to complete
Unlock access to complete
Funding Insights of Quris Ai
Quris Ai has successfully raised a total of $37M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $9 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quris Ai
Quris Ai has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include iAngels, SoftBank Vision Fund and GlenRock Israel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology and startups.
|
Locked | Locked | Locked | |
|
Private equity investments are targeted in Israel and the US.
|
Locked | Locked | Locked | |
|
WellTech Ventures is focused on investing in wellness technology startups.
|
Locked | Locked | Locked |
Investor details for Quris Ai
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quris Ai
Quris Ai has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nortis.
Investment portfolio details for Quris Ai
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small human tissue segments are generated in microfluidic chips.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Quris Ai
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Quris Ai
Detailed financials for Quris Ai
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quris Ai Comparisons
Peer comparison for Quris Ai
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quris Ai
Quris Ai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sable Bio, Mensura Health, Intero Biosystems, Metsystem and Pharmacovigilance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug safety risks are predicted via AI in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Mensura Health is focused on epilepsy patient management solutions.
|
|
| Locked | Locked | Locked |
Develops human organoids for preclinical drug testing and research applications.
|
|
| Locked | Locked | Locked |
Offers advanced drug screens for predicting cancer metastasis and personalized treatments.
|
|
| Locked | Locked | Locked |
Delivers data analytics dashboards for drug safety professionals.
|
|
| Locked | Locked | Locked |
EMESO enhances medicines safety and efficiency with digital healthcare solutions.
|
Detailed competitors of Quris Ai
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quris Ai
Complete news archive for Quris Ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quris Ai
Quris Ai was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Quris Ai is headquartered in Tel Aviv-yafo, Israel. It is registered at Tel Aviv-yafo, Tel Aviv District, Israel.
Isaac Bentwich is the current CEO of Quris Ai. They have also founded this company.
Quris Ai is a funded company, having raised a total of $37M across 3 funding rounds to date.
Quris AI was founded in 2020 within the healthcare and biotechnology sector. Software is developed to support drug development processes through AI-driven predictions. Key features encompass clinical predictive analytics, clinical trial oversight, and overall drug development management. Operations center on enhancing efficiency for pharmaceutical workflows, with tools tailored for professional use in drug discovery and validation.
Quris Ai's top competitors include Sable Bio, Mensura Health and Intero Biosystems.
Quris Ai offers Bio-AI Clinical Prediction Platform.
Quris Ai has made 1 acquisition, including Nortis.
Quris Ai has 7 investors. Key investors include iAngels, SoftBank Vision Fund, GlenRock Israel, WellTech Ventures, and Judith Richter.